Was Roche’s $89 per share offer for Genentech a true “fair and generous” offer, or just the first move in a long chess match? Genentech’s independent directors seem to believe the latter.
Tasked with responding to the offer, the independent directors said today that the bid “substantially undervalues the company.” But they also made clear that [...]
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment